论文部分内容阅读
目的探讨针对性的个体化心理护理对肾癌根治术后应用干扰素治疗患者健康状况的影响。方法选取南阳市某医院泌尿外科2013年1—6月住院诊治的58例肾功能正常的单侧肾癌患者为研究对象,采用随机分组法将患者分为对照组和研究组各29例。对照组采取常规护理;研究组患者在常规护理基础上实施住院期间全程持续个体化心理护理干预。治疗结束后第14天和第28天使用使用抑郁自评量表(self-rating depression scale,SDS)及焦虑自评量表(self-rating anxiety scale,SAS)评价患者相关健康状况,并在术后第12周采用生活质量评定标准(quality of life,QOL)进行测评。两组间计量资料比较采用独立样本t检验,组内比较采用配对t检验,P<0.05为差异有统计学意义。结果两组患者干预前后SDS评分[(56.27±14.39)、(54.88±12.61)分与(54.82±13.26)、(31.03±10.22)分]比较,差异均有统计学意义(t=2.756、5.873,均P<0.05);研究组干预前后SAS评分[(52.03±16.87)、(32.87±8.64)分]比较,差异有统计学意义(t=3.651,P<0.05)。干预后两组患者SDS、SAS评分比较,差异均有统计学意义(均P<0.05)。术后第12周后,两组患者的食欲、精神、睡眠、疼痛、自身对癌症的认识、日常生活、治疗的不良反应、面部表情评分及总分[(2.37±0.68)、(2.41±0.62)、(2.36±0.87)、(2.24±0.28)、(2.85±0.53)、(2.83±0.41)、(3.26±0.57)、(2.62±0.72)、(27.52±0.49)分与(3.27±0.43)、(3.89±0.72)、(3.48±0.61)、(3.36±0.59)、(3.55±0.81)、(3.49±0.91)、(2.47±0.39)、(3.31±0.92)、(33.62±0.51)分]比较,差异均有统计学意义(均P<0.05)。结论个体化心理护理能使肾癌根治术后应用干扰素治疗患者更好地利用积极的行为和认知应对癌症,利于术后健康状况的全面恢复,对降低并发症发生率具有重要意义。
Objective To explore the impact of personalized psychotherapy on the health status of patients with interferon after radical operation of renal cell carcinoma. Methods Fifty-eight patients with unilateral renal cell carcinoma with normal renal function were selected as the research object from January 2006 to January 2006 in a urology department of Nanyang City. Patients were divided into control group and study group by randomization. The control group to take routine care; study group patients on the basis of routine care during the implementation of continuous throughout the individualized psychological nursing intervention. On the 14th and 28th days after the end of treatment, the use of self-rating depression scale (SDS) and self-rating anxiety scale (SAS) After 12 weeks, the quality of life (QOL) was used for evaluation. Measurement data between two groups were compared using independent samples t test, the group was compared using paired t test, P <0.05 for the difference was statistically significant. Results Before and after the intervention, the scores of SDS in the two groups were statistically significant (t = 2.756,5.873, P <0.05), and were significantly higher than those before the intervention (56.27 ± 14.39, 54.88 ± 12.61 and 54.82 ± 13.26, respectively, 31.03 ± 10.22) (P <0.05). The SAS scores in the study group before and after intervention [(52.03 ± 16.87), (32.87 ± 8.64) points] were significantly different (t = 3.651, P <0.05). There were significant differences in SDS and SAS scores between the two groups after intervention (all P <0.05). After 12 weeks, the appetite, mental status, sleep, pain, self-awareness of cancer, daily life, adverse reactions to treatment, facial expression score and total score [(2.37 ± 0.68), (2.41 ± 0.62 (2.36 ± 0.87), (2.24 ± 0.28), (2.85 ± 0.53), (2.83 ± 0.41), (3.26 ± 0.57), (2.62 ± 0.72), (27.52 ± 0.49) (3.89 ± 0.72), (3.48 ± 0.61), (3.36 ± 0.59), (3.55 ± 0.81), (3.49 ± 0.91), (2.47 ± 0.39), (3.31 ± 0.92), (33.62 ± 0.51) Comparison, the differences were statistically significant (P <0.05). Conclusion Individualized psychological care can make the patients with interferon treatment after radical mastectomy of kidney cancer better utilize the positive behavior and cognition to cope with the cancer, which is conducive to the full recovery of postoperative health status and is of great significance to reduce the incidence of complications.